Mark

This is my beloved big brother. If anyone has any info, please get in touch

#AVCT shareholders will feel the full impact of this appointment not today but when the board is deciding which offer to recommend to shareholders. Board now ultra lean. Coughlin, Hughes + x3 NEDs. No bloat. Little waste. Unrecognisable from 12 months ago.

In my personal view 2026 will be a defining point for #AVCT and ultimately for long term cancer patients. Thanks to all shareholders and stakeholders for their support.

Delighted to be appointed as chairman of #AVCT My core priority is to ensure the value of preCISION is exploited to its fullest, for the benefit of all shareholders. I am more than confident we have the team and the intellectual property to enable this.

Avacta today announces that Richard Hughes, one of Avacta’s non-executive Directors, will become non-executive Chairman of Avacta following the Annual General Meeting (AGM) on June 22, 2026. avacta.com/board-director… #AVCT

The double!🏆🏆💚🤍

Honestly, this is all just becoming a little sad to see. Especially from normally rational people. For the record, Andy is a sound guy. With rangers* as city rivals, we're used to sore losers but the hysteria this last week has been something else. The handball at Motherwell has been proven to be a handball. The final game has been proven to have been concluded, not abandoned (as if it matters with a 2 goal advantage) and no Hearts player was assaulted. Yes, some were subjected to some hurty words but the only person to raise their hands on that pitch was Shankland (on camera!). Its about time your fans (and others) tried growing up and acting like adults. Hearts lost because their away form crumbled, while celtic finished she season strong. On the final day, McInnes set up hoping for a draw, and lost. There was no conspiracy, Hearts weren't cheated. They just weren't good enough at the end of the day. They could have admitted this and aimed to improve next year but (like rangers*) have decided to make excuses instead. This suits Celtic because (like rangers* over the last 10 years), they won't feel the need to improve, since they think they were already good enough to win. If Hearts want to compete at this level, their fans are going to have to learn that sometimes, things don't months end you want them to.

“The reality is that Celtic weren't handed dominance by those in positions of power- they earned it in spite of them” ~ Kelly Given 💚 The National ☕️🥐

We are delighted to share the video recording of Science Day 2026 from #AVCT. Our team put so much into this day and their combined efforts shine through. We are thrilled to welcome a special guest in Part 2 #FOCUSOnTheWin #HopeWithoutCompromise #ThisIsTheTeam

We’re pleased to share the recordings from our Science Day. The presentations explore comparative analyses of pre|CISION® payload delivery with AVA6103 vs approved ADCs, alongside updated in vivo studies of the AVA6207 dual payload delivery system. avacta.com/2026-science-d… #AVCT

The last time #AVCT was in the 100s was early 2024. Since then, the progress made by @avacta has been significant. The next 6 months are loaded up with catalysts. The valuation disconnect can't continue to be ignored. C'mon the Avacta ⏰🚀

The wee guy started a video and just happened to catch the 3rd goal 😳 🤣🙌 Absolute carnage! 🤪🤪🤪 Just beautiful! 😊 Happy Sunday! 💚🍀💚🍀💚🍀 @M_daizen_1020 @CelticFC @JamseyMcBride

#AVCT featured as a small cap to buy in May 2026 in a report by Clear Capital Markets published this afternoon. (Can't link to PDF - can be found on Google)

Morning weekly chart is COOKING #AVCT ✅ Minervini Trend Template turned GREEN ✅ 18-month base breakout in play ✅ Weekly MACD bullish cross ✅ RSI at 64 room to run ✅ Wyckoff accumulation structure 82 > 89p Close above that on volume = Stage 2 confirmed Fib targets: 127p → 158p → 190p NFA | DYOR 🙏

#AVCT sitting right at the Weekly 200MA. “How fast?” The market has no real concept of time. This is a weekly chart, so my initial target is around 110p over the coming weeks, not days. Patience pays, though many of you probably know that even better than I do. If price can reclaim and hold above the 200MA, I suspect the move could accelerate quickly.

✅ #AVCT’s tech is dynamite ✅ Team is absurdly talented ✅ there’s a maturity to (pre)clinical + commercial progress ✅ taking time to do it right will pay back ✅ FDA = a friendly counterparty ✅ independent doctors are excited about 6103 ✅ Nearterm: data + IP (+ deals?) 6/6

Very Important Message!! Do NOT, and I repeat do not buy plants treated with Neonicotinoids. Bees take the pollen back to the hive and feed it to the brood. This is a number one cause of the colony collapse. It's important to NOT buy these plants! Make sure to share this post!

We are delighted to share the next chapter of #AVCT next week. Very much looking forward to seeing all of our guests in London in T-minus 7 days #LetsDoThis #HopeWithoutCompromise #FOCUSOnTheWin

We're looking forward to welcoming attendees on May 6 to the Royal Society of Chemistry, London, for presentations on our scientific achievements and the road ahead for our tumor-activated oncology platform, followed by a reception. #AVCT

This excerpt, from the Prometheus biotech podcast, is hitting harder now given the multiple times #AVCT have directly and recently compared their 2nd generation pre|CISION exatecan, AVA6103, to AS/DS's best-selling ADC, Enhertu. You just dont do that unless you're insanely confident in what you're seeing. Like Prometheus were with PRA023. Full podcast available in the replies to the above tweet for those that haven't watched it. Many, MANY synergies with Avacta and well worth a watch 👍 Eventually Prometheus were bought for around £10Bn by Merck and they didnt have a fraction of the potential Avacta have.